Pancreatic b-cell response to increased metabolic demand and to pharmacologic secretagogues requires epac2a

Diabetes

Volumn 62, Issue 8, 2013, Pages 2796-2807

  Song, Woo Jin ^a   Mondal, Prosenjit ^a   Li, Yuanyuan ^a   Lee, Suh Eun ^a   Hussain, Mehboob A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP ISLET BRAIN ISOFORM 2A; G PROTEIN COUPLED RECEPTOR 40; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; SHORT HAIRPIN RNA; SYNAPTOBREVIN 2; SYNTAXIN 1A; UNCLASSIFIED DRUG; CALCIUM; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSULIN; RAPGEF4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; DIET; ENZYME DEFICIENCY; EXOCYTOSIS; GENE EXPRESSION; GLUCOSE STIMULATED INSULIN SECRETION; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; KNOCKOUT MOUSE; LIPID DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; WILD TYPE; ANIMAL; DRUG EFFECT; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; PANCREAS; PHYSIOLOGY; SIGNAL TRANSDUCTION; DRUG EFFECTS;

ANIMALS; CALCIUM; GLUCOSE; GLUCOSE TOLERANCE TEST; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; PANCREAS; SIGNAL TRANSDUCTION;

EID: 84891698714     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1394     Document Type: Article

References (42)

1. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-333
2. DeFronzo RA, Abdul-Ghani MA. Preservation of b-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 2011;96:2354-2366
3. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165
4. Song WJ, Seshadri M, Ashraf U, et al. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab 2011;13:308- 319
5. Zhang CL, Katoh M, Shibasaki T, et al. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 2009;325:607-610
6. Chepurny OG, Kelley GG, Dzhura I, et al. PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-29-O-MecAMP- AM in human islets of Langerhans. Am J Physiol Endocrinol Metab 2010;298:E622-E633
7. Kang G, Chepurny OG, Rindler MJ, et al. A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells. J Physiol 2005;566:173-188
8. Shibasaki T, Takahashi H, Miki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA 2007;104:19333-19338
9. Südhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science 2009;323:474-477
10. D-skeland SO, Ogreid D. Binding proteins for cyclic AMP in mammalian tissues. Int J Biochem 1981;13:1-19
11. Ekanger R, Sand TE, Ogreid D, Christoffersen T, Døskeland SO. The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes. J Biol Chem 1985;260:3393-3401
12. Salehi A, Flodgren E, Nilsson NE, et al. Free fatty acid receptor 1 (FFA(1) R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 2005;322:207-215
13. Tan CP, Feng Y, Zhou YP, et al. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes 2008;57:2211-2219
14. Seino S, Takahashi H, Takahashi T, Shibasaki T. Treating diabetes today: a matter of selectivity of sulphonylureas. Diabetes Obes Metab 2012;14 (Suppl. 1):9-13
15. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001;294:564-567
16. Kirschner LS, Kusewitt DF, Matyakhina L, et al. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 2005;65:4506-4514
17. Song WJ, Schreiber WE, Zhong E, et al. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 2008;57:2371-2381
18. Hussain MA, Porras DL, Rowe MH, et al. Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Mol Cell Biol 2006;26:7747-7759
19. Fernandez-Mejia C, Vega-Allende J, Rojas-Ochoa A, et al. Cyclic adenosine 39,59-monophosphate increases pancreatic glucokinase activity and gene expression. Endocrinology 2001;142:1448-1452
20. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000;74:10074-10080
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408
22. Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2000;2:805-811
23. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guaninenucleotide- exchange factor directly activated by cyclic AMP. Nature 1998; 396:474-477
24. Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998;282:2275-2279
25. Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMP-GEFII - Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 2001;276: 46046-46053
26. Kelley GG, Chepurny OG, Schwede F, et al. Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-MecAMP- AM. Islets 2009;1:260-265
27. Dzhura I, Chepurny OG, Leech CA, et al. Phospholipase C-́ links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans. Islets 2011;3:121-128
28. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006;55 (Suppl. 2):S16-S23
29. Peyot ML, Pepin E, Lamontagne J, et al. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes 2010;59:2178-2187
30. Araki T, Hirayama M, Hiroi S, Kaku K. GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab 2012;14:271-278
31. Ferdaoussi M, Bergeron V, Zarrouki B, et al. G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1. Diabetologia 2012;55:2682-2692
32. Islam D, Zhang N, Wang P, et al. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. Am J Physiol Endocrinol Metab 2009;296:E174-E181
33. Rorsman P, Braun M. Regulation of Insulin Secretion in Human Pancreatic Islets. Annu Rev Physiol 2013;75:155-179
34. Leech CA, Dzhura I, Chepurny OG, Schwede F, Genieser HG, Holz GG. Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac. Islets 2010;2:72-81
35. Leech CA, Dzhura I, Chepurny OG, et al. Molecular physiology of glucagon- like peptide-1 insulin secretagogue action in pancreatic b cells. Prog Biophys Mol Biol 2011;107:236-247
36. Seino S. Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea. Diabetologia 2012;55:2096-2108
37. Seino S, Shibasaki T, Minami K. Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment. Proc Jpn Acad, Ser B, Phys Biol Sci 2010;86:563-577
38. Holz GG 4th, Kühtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993;361:362-365
39. Kang G, Chepurny OG, Malester B, et al. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J Physiol 2006;573:595-609
40. Kang G, Leech CA, Chepurny OG, Coetzee WA, Holz GG. Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells. J Physiol 2008;586:1307-1319
41. Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG. Cell physiology of cAMP sensor Epac. J Physiol 2006;577:5-15
42. Lemmens R, Larsson O, Berggren PO, Islam MS. Ca2+-induced Ca2+ release from the endoplasmic reticulum amplifies the Ca2+ signal mediated by activation of voltage-gated L-type Ca2+ channels in pancreatic betacells. J Biol Chem 2001;276:9971-9977